Forte Biosciences (FBRX) Misses Q2 EPS by 4c
Forte Biosciences (NASDAQ: FBRX) reported Q2 EPS of ($0.21), $0.04 worse than the analyst estimate of ($0.17).
For earnings history and earnings-related data on Forte Biosciences (FBRX) click here.
Forte Biosciences (NASDAQ: FBRX) reported Q2 EPS of ($0.21), $0.04 worse than the analyst estimate of ($0.17).
For earnings history and earnings-related data on Forte Biosciences (FBRX) click here.